HPPD stands for Hallucinogen Persisting Perception Disorder, a condition in which visual disturbances continue long after a hallucinogenic drug has left the body. It affects roughly 4.2% of people who use hallucinogens, and the visual symptoms can last months or years. Unlike a flashback that comes and goes in seconds, HPPD involves recurring or even constant changes in the way you see the world.
What HPPD Looks and Feels Like
The hallmark of HPPD is visual disturbance that wasn’t there before drug use. In clinical case series, visual snow (a static-like grain across your entire field of vision, similar to an old television with poor reception) appears in virtually every documented case. Other common symptoms include palinopsia (seeing an afterimage that lingers after you look away from an object), light sensitivity, floaters, and difficulty seeing in the dark.
Less common but well-documented symptoms include tracers (trails behind moving objects), halos around lights, enhanced or shifted colors, objects appearing larger or smaller than they are, and altered perception of motion or distance. Some people describe geometric patterns or flickering in their peripheral vision. These aren’t full hallucinations. You remain aware that what you’re seeing isn’t real, which is a key distinction from psychotic disorders.
Beyond the visual symptoms, many people with HPPD experience feelings of detachment from themselves or their surroundings. Episodes can arrive with a kind of “aura,” similar to what some migraine sufferers describe, accompanied by mild bewilderment or a sense of unreality.
Type I vs. Type II
Clinicians sometimes distinguish between two forms, though this split isn’t yet formalized in the DSM-5. Type I is milder: episodes are brief, less frequent, and typically begin with subtle warning signs like a gentle sense of detachment. Type II is more severe. It can strike without warning, with intense depersonalization and more frequent, persistent visual disturbances. People with Type II generally have a worse prognosis and a harder time reaching full recovery.
Which Drugs Cause It
LSD is the substance most commonly associated with HPPD, implicated in about 64% of cases in one large review. Cannabis is a close second at 56%, which surprises many people who think of it as a low-risk drug. MDMA (ecstasy) accounts for roughly 31% of cases. Psilocybin mushrooms, ketamine, ayahuasca, synthetic cannabinoids, and even over-the-counter cough suppressants containing dextromethorphan have all been linked to the condition. Some cases have been reported after a single use, while others develop after repeated exposure.
Cannabis deserves particular attention because it can both trigger HPPD on its own and worsen symptoms in people who already have it. Several documented cases involve synthetic cannabis products, which tend to be more potent and unpredictable than natural cannabis.
What Happens in the Brain
The leading theory centers on a disruption in the brain’s visual processing system. Your visual cortex contains small inhibitory nerve cells that release a calming chemical called GABA. These cells act like a filter, dampening unnecessary visual noise so you perceive a clean, stable image. They’re activated in part by serotonin receptors, the same receptors that hallucinogens target.
The hypothesis is that an intense hallucinogenic experience damages or destabilizes these inhibitory cells. With the filter weakened, excitatory signals in the visual cortex go unchecked. Computational models show that increasing excitatory input to the primary visual cortex can produce symptoms like halos and visual snow, while a deeper imbalance between excitation and inhibition generates more complex distortions like tracers and geometric patterns. In short, the brain’s visual “noise cancellation” is stuck in a partially broken state.
Conditions That Often Accompany HPPD
HPPD rarely exists in isolation. In a systematic review of documented cases, about a third of patients had a co-occurring substance-use disorder. Depression and anxiety each appeared in roughly 8% of cases, and psychotic disorders in about 6%. These numbers likely undercount the real overlap, since many patients with substance-use disorder also reported significant anxiety or depressive symptoms without a formal diagnosis.
The presence of depression or anxiety matters for prognosis. Patients with either condition, and especially both, tend to have longer-lasting HPPD symptoms and respond less well to treatment. The visual disturbances themselves often fuel anxiety, creating a cycle where worry about symptoms makes the symptoms more noticeable and distressing.
How HPPD Overlaps With Visual Snow Syndrome
Visual snow syndrome (VSS) produces many of the same symptoms as HPPD: static across the visual field, afterimages, light sensitivity, and floaters. The critical difference is cause. VSS occurs in people who have never used hallucinogens, and its origin appears to be a separate neurological issue. In practice, the two conditions look almost identical on a symptom checklist. Diagnosis depends heavily on a thorough drug-use history. If visual snow appears after hallucinogen exposure, it’s classified as HPPD. If there’s no drug history, it’s VSS. This distinction matters because the treatment approach and triggers differ.
Treatment Approaches
There is no single cure for HPPD, but two medication strategies have shown the most consistent benefit. Benzodiazepines, particularly clonazepam, have provided significant relief in multiple clinical reports. In one observational study of 16 patients taking clonazepam for two months, patients reported meaningful reduction in both the frequency and intensity of visual disturbances, and improvements held during a six-month follow-up period. Other types of sedatives in the same class have been less effective, so the specific choice of medication matters.
Lamotrigine, an anti-seizure medication, has also shown promise. In one well-documented case, a patient on lamotrigine for 12 months saw some symptoms vanish entirely, including distortions of object size and a sensation of floating, while others like afterimages and halos became noticeably less frequent. Improvement began even at low initial doses before reaching the full therapeutic level. This fits with the theory that HPPD involves excess excitatory activity in the visual cortex, since lamotrigine works by calming that excitatory signaling.
One important caution: certain antipsychotic medications, particularly newer “atypical” antipsychotics, have been reported to make HPPD symptoms worse. This is a meaningful risk because HPPD can initially be misdiagnosed as a psychotic disorder, leading to exactly the wrong treatment.
Living With HPPD
The most practical step for anyone with HPPD is complete abstinence from the substances that triggered it. Cannabis use in particular has been shown to provoke symptom flares or prevent recovery. Continued use of any hallucinogenic substance carries a clear risk of worsening and prolonging the condition.
Episodes can be triggered spontaneously or by identifiable factors, though the specific triggers vary from person to person. Stress, fatigue, and dark environments (where visual snow and floaters become more noticeable) are commonly reported aggravators. Some people find that the condition gradually fades over months or years, particularly with the milder Type I form. Others, especially those with Type II or co-occurring depression, experience symptoms that persist indefinitely. The variability makes it difficult to give a single timeline, but early treatment and substance avoidance are consistently associated with better outcomes.